+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peptide Antibiotics Market Size, Share & Trends Analysis Report by Product Type, by Disease, by Route Of Administration (Oral, Injectable, Topical), by Distribution Channel, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • July 2022
  • Region: Global
  • Grand View Research
  • ID: 5644997
Description Jump to:
The global peptide antibiotics market size is expected to reach USD 6.6 billion by 2030. The market is expected to expand at a CAGR of 4.6% from 2022 to 2030. The market is expected to witness growth opportunities owing to factors such as the increasing research and development activities in field of peptide antibiotics coupled with high number of drug approvals. Moreover, surge in cases of antimicrobial resistance cases and possibility of side effects from the conventional antibiotics are also expected to drive the market during the forecast period.

Increasing prevalence of cancer and other infectious diseases are expected to propel the growth over the forecast period. For instance, according to the CDC, United States reported 1,752,735 new cancer cases along with 599,589 deaths in 2019. For every 100,000 people, 439 new cases were found and 146 people died due to cancer. Further, according to Globocan 2020, U.K. had 457,960 new cases with 179,648 deaths in 2020. The most common types of malignancies were breast, prostate cancer and Non-Hodgkin’s lymphoma.

There are some of the peptide antibiotics which are used to treat cancers such as, NHL, Hodgkin’s lymphoma, and certain types of skin malignancies. According to Globocan 2020, there were 5,44,352 Non-Hodgkin lymphoma cases and 83,087 Hodgkin’s lymphoma cases. The efficiency of various existing products is expected to result into higher revenues owing to doctor recommendations . For instance, BLEOMYCIN for injection USP is the mixture of cytotoxic glycopeptide antibiotics that is isolated from Streptomyces verticillus and is used for the treatment of testicular carcinoma, squamous cell carcinoma, and various types of lymphomas.

Moreover, ongoing product approvals and strategic initiatives undertaken by market players such as partnerships, collaborations, product launches, and expansions are expected to fuel market growth during forecast period. For instance, in July 2021, AbbVie Inc announced that the U.S. FDA approved DALVANCE for the treatment of acute bacterial skin and skin structure infections in pediatric patients from birth. Moreover, in July 2020, Sandoz International GmbH announced introduction of Daptomycin injection 500 mg, a generic version of Cubicin, in the U.S. market for the treatment of adult patients with complicated skin and skin structure infections and several type of bloodstream infections.

Peptide Antibiotics Market Report Highlights

  • In 2021, the non-ribosomal synthesized peptide segment dominated the market owing to their higher demand
  • The retail pharmacy segment held the highest share and is likely to maintain its dominance throughout the forecast period
  • Asia Pacific region is expected to witness the highest CAGR over the forecast period owing to factors such as, rising prevalence of infectious diseases, and availability of large patient pool
  • North America dominated the overall market in 2021 due to the higher demand for peptide antibiotics products, presence of leading market players, and increased research activities within the region

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: commodity flow approach
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Peptide Antibiotics Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Increasing adoption of peptide antibiotics in hospitals and clinics
3.1.1.2 Increasing incidences of microbial resistance
3.1.2 Market Restraint Analysis
3.1.2.1 Side-effects associated with peptide antibiotics
3.2 Penetration and Growth Prospect Mapping
3.3 Business Environment Analysis Tools
3.3.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.3.2 Porter’s Five Forces Analysis
3.3.3 Industry Analysis - Ansoff Matrix
3.4 Pricing Analysis
3.5 Regulatory Scenario
Chapter 4 Regulatory & Political Forces
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Heat map analysis
4.2 Company Categorization
4.2.1 Innovators
4.2.2 Market Leaders
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.3.3 Key company market share analysis, 2021
4.4 Public Companies
4.4.1 Company market position analysis
4.4.1.1 Market differentiators
4.5 Private Companies
4.5.1 List of key emerging companies
4.6 Major Deals and Strategic Alliances Analysis
4.6.1 New product launch
4.6.2 Acquisitions
4.6.3 Expansion
4.6.4 Licensing and partnerships
Chapter 5 Peptide Antibiotics Market - Segment Analysis, By Product Type, 2018 - 2030 (USD Million)
5.1 Product Type Market Share Analysis, 2021 & 2030 (USD Million)
5.2 Segment Dashboard
5.3 Market Size & Forecasts and Trend Analysis, 2018 - 2030 (USD Million)
5.3.1 Ribosomal Synthesized Peptide Antibiotics
5.3.1.1 Ribosomal synthesized peptide antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
5.3.2 Non-Ribosomal Synthesized Peptide Antibiotics
5.3.2.1 Non-ribosomal synthesized peptide antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6 Peptide Antibiotics Market - Segment Analysis, By Disease, 2018 - 2030 (USD Million)
6.1 Disease Market Share Analysis, 2021 & 2030 (USD Million)
6.2 Segment Dashboard
6.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
6.3.1 Skin Infections
6.3.1.1 Skin infections market estimates and forecast, 2018 - 2030 (USD Million)
6.3.2 HABP/VABP
6.3.2.1 HABP/VABP market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3 Blood Stream Infection
6.3.3.1 Blood stream infection market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4 Others
6.3.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7 Peptide Antibiotics Market - Segment Analysis, By Route of Administration, 2018 - 2030 (USD Million)
7.1 Route of Administration Market Share Analysis, 2021 & 2030 (USD Million)
7.2 Segment Dashboard
7.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
7.3.1 Oral
7.3.1.1 Oral market estimates and forecast, 2018 - 2030 (USD Million)
7.3.2 InjecTable
7.3.2.1 InjecTable market estimates and forecast, 2018 - 2030 (USD Million)
7.3.3 Topical
7.3.3.1 Topical market estimates and forecast, 2018 - 2030 (USD Million)
7.3.4 Others
7.3.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8 Peptide Antibiotics Market - Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
8.1 Distribution Channel Market Share Analysis, 2021 & 2030 (USD Million)
8.2 Segment Dashboard
8.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
8.3.1 Hospital Pharmacies
8.3.1.1 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
8.3.2 Retail Pharmacies
8.3.2.1 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
8.3.3 Online Pharmacies
8.3.3.1 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9 Peptide Antibiotics Market - Segment Analysis, By Region, 2018 - 2030 (USD Million)
9.1 Regional Market Share Analysis, 2021 & 2030 (USD Million)
9.2 Regional Market Dashboard
9.3 North America
9.3.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
9.3.2 U.S.
9.3.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
9.3.3 Canada
9.3.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
9.4 Europe
9.4.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
9.4.2 Germany
9.4.2.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
9.4.3 U.K.
9.4.3.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
9.4.4 Spain
9.4.4.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
9.4.5 France
9.4.5.1 France market estimates and forecast, 2018 - 2030 (USD Million)
9.4.6 Italy
9.4.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
9.5 Asia Pacific
9.5.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
9.5.2 Japan
9.5.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
9.5.3 China
9.5.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
9.5.4 India
9.5.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
9.5.5 South Korea
9.5.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
9.5.6 Australia
9.5.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
9.6 Latin America
9.6.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2 Brazil
9.6.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3 Mexico
9.6.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
9.6.4 Argentina
9.6.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
9.7 Middle East & Africa
9.7.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
9.7.2 South Africa
9.7.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
9.7.3 UAE
9.7.3.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)
9.7.4 Saudi Arabia
9.7.4.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 10 Competitive & Vendor Landscape
10.1 Participant Categorization
10.1.1 Innovators
10.1.2 Market Leaders
10.2 Strategy Mapping
10.2.1 Key Strategies Chosen by Players in this Market Include:
10.2.1.1 Launch of new products
10.2.1.2 Acquisition
10.2.1.3 Expansion
10.2.1.4 Agreements, collaborations, partnerships
10.2.1.5 Others (realignment, divestment, market penetration):
10.3 Strategic Framework
10.3.1 Key Company Market Share Analysis, 2021
10.4 Company Profiles
10.4.1 Pfizer Inc.
10.4.1.1 Company overview
10.4.1.2 Financial performance
10.4.1.3 Product benchmarking
10.4.1.4 Strategic initiatives
10.4.2 Sandoz International GmbH
10.4.2.1 Company overview
10.4.2.2 Financial performance
10.4.2.3 Product benchmarking
10.4.2.4 Strategic initiatives
10.4.3 GSK Group of Companies.
10.4.3.1 Company overview
10.4.3.2 Financial performance
10.4.3.3 Product benchmarking
10.4.3.4 Strategic initiatives
10.4.4 AbbVie Inc
10.4.4.1 Company overview
10.4.4.2 Financial performance
10.4.4.3 Product pipeline
10.4.4.4 Strategic initiatives
10.4.5 Merck & Co., Inc
10.4.5.1 Company overview
10.4.5.2 Financial performance
10.4.5.3 Product pipeline
10.4.5.4 Strategic initiatives
10.4.6 Xellia PHARMACEUTICALS
10.4.6.1 Company overview
10.4.6.2 Product benchmarking
10.4.6.3 Strategic initiatives
10.4.7 Theravance Biopharma
10.4.7.1 Company overview
10.4.7.2 Financial performance
10.4.7.3 Product benchmarking
10.4.8 AuroMedics Pharma LLC
10.4.8.1 Company overview
10.4.8.2 Financial performance
10.4.8.3 Product benchmarking
10.4.8.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America Peptide Antibiotics Market, By Country, 2018-2030 (USD Million)
Table 4 North America Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 5 North America Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 6 North America Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 7 North America Peptide Antibiotics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 8 U.S. Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 9 U.S. Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 10 US Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 11 US Peptide Antibiotics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 12 Canada Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 13 Canada Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 14 Canada Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 15 Canada Peptide Antibiotics Market, By Distribution Channel, 2018-2030 (USD Million)
Table 16 Europe Peptide Antibiotics Market, By Country, 2018-2030 (USD Million)
Table 17 Europe Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 18 Europe Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 19 Europe Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 20 Europe Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 21 U.K. Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 22 U.K. Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 23 U.K. Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 24 U.K. Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 25 Germany Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 26 Germany Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 27 Germany Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 28 Germany Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 29 France Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 30 France Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 31 France Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 32 France Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 33 Spain Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 34 Spain Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 35 Spain Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 36 Spain Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 37 Italy Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 38 Italy Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 39 Italy Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 40 Italy Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 41 Asia Pacific Peptide Antibiotics Market, By Country, 2018-2030 (USD Million)
Table 42 Asia Pacific Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 43 Asia Pacific Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 44 Asia Pacific Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 45 Asia Pacific Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 46 Japan Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 47 Japan Peptide Antibiotics Market, By Disease 2018-2030 (USD Million)
Table 48 Japan Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 49 Japan Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 50 China Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 51 China Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 52 China Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 53 China Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 54 India Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 55 India Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 56 India Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 57 India Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 58 South Korea Peptide Antibiotics Market, By Product Type2018-2030 (USD Million)
Table 59 South Korea Peptide Antibiotics Market, By Disease 2018-2030 (USD Million)
Table 60 South Korea Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 61 South Korea Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 62 Australia Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 63 Australia Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 64 Australia Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 65 Australia Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 66 Latin America Peptide Antibiotics Market, By Country, 2018-2030 (USD Million)
Table 67 Latin America Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 68 Latin America Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 69 Latin America Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 70 Latin America Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 71 Brazil Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 72 Brazil Peptide Antibiotics Market, By Disease 2018-2030 (USD Million)
Table 73 Brazil Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 74 Brazil Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 75 Mexico Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 76 Mexico Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 77 Mexico Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 78 Mexico Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 79 Argentina Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 80 Argentina Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 81 Argentina Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 82 Argentina Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 83 Middle East & Africa Peptide Antibiotics Market, By Country, 2018-2030 (USD Million)
Table 84 Middle East & Africa Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 85 Middle East & Africa Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 86 Middle East & Africa Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 87 Middle East & Africa Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 88 South Africa Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 89 South Africa Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 90 South Africa Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 91 South Africa Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 92 Saudi Arabia Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 93 Saudi Arabia Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 94 Saudi Arabia Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 95 Saudi Arabia Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
Table 96 UAE Peptide Antibiotics Market, By Product Type, 2018-2030 (USD Million)
Table 97 UAE Peptide Antibiotics Market, By Disease, 2018-2030 (USD Million)
Table 98 UAE Peptide Antibiotics Market, By Route of Administration, 2018-2030 (USD Million)
Table 99 UAE Peptide Antibiotics Market, Distribution Channel, 2018-2030 (USD Million)
List of Figures
Fig. 1 Peptide antibiotics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Peptide antibiotics market snapshot
Fig. 10 Peptide antibiotics market driver impact
Fig. 11 Peptide antibiotics market restraint impact
Fig. 12 Penetration and growth prospect mapping
Fig. 13 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 14 Porter’s five forces analysis
Fig. 15 Ansoff matrix
Fig. 16 Peptide antibiotics market: Product type outlook and key takeaways
Fig. 17 Peptide antibiotics market: Product type movement analysis
Fig. 18 Product type segment dashboard
Fig. 19 Ribosomal synthesized peptide antibiotics market estimates and forecast, 2018-2030 (USD Million)
Fig. 20 Non-ribosomal synthesized peptide antibiotics market estimates and forecast, 2018-2030 (USD Million)
Fig. 21 Peptide antibiotics market: Disease outlook and key takeaways
Fig. 22 Peptide antibiotics market: Disease movement analysis
Fig. 23 Disease segment dashboard
Fig. 24 Skin infections market estimates and forecast, 2018-2030 (USD Million)
Fig. 25 HABP/VABP market estimates and forecast, 2018-2030 (USD Million)
Fig. 26 Blood stream infections market estimates and forecast, 2018-2030 (USD Million)
Fig. 27 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 28 Peptide antibiotics market: Route of Administration outlook and key takeaways
Fig. 29 Peptide antibiotics market: Route of Administration movement analysis
Fig. 30 Route of Administration segment dashboard
Fig. 31 Oral market estimates and forecast, 2018-2030 (USD Million)
Fig. 32 InjecTable market estimates and forecast, 2018-2030 (USD Million)
Fig. 33 Topical market estimates and forecast, 2018-2030 (USD Million)
Fig. 34 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 35 Peptide antibiotics market: Distribution channel outlook and key takeaways
Fig. 36 Peptide antibiotics market: Distribution channel movement analysis
Fig. 37 Distribution channel segment dashboard
Fig. 38 Hospital pharmacies market estimates and forecast, 2018-2030 (USD Million)
Fig. 39 Retail pharmacies market estimates and forecast, 2018-2030 (USD Million)
Fig. 40 Online pharmacies market estimates and forecast, 2018-2030 (USD Million)
Fig. 41 Peptide antibiotics market: regional outlook and key takeaways
Fig. 42 Regional outlook, 2021 & 2030 (USD Million)
Fig. 43 Regional market dashboard
Fig. 44 North America
Fig. 45 North America market estimates and forecast, 2018-2030 (USD Million)
Fig. 46 U.S.
Fig. 47 U.S. market estimates and forecast, 2018-2030 (USD Million)
Fig. 48 Canada
Fig. 49 Canada market estimates and forecast, 2018-2030 (USD Million)
Fig. 50 Europe
Fig. 51 Europe market estimates and forecast, 2018-2030 (USD Million)
Fig. 52 Germany
Fig. 53 Germany market estimates and forecast, 2018-2030 (USD Million)
Fig. 54 U.K.
Fig. 55 U.K. market estimates and forecast, 2018-2030 (USD Million)
Fig. 56 Spain
Fig. 57 Spain market estimates and forecast, 2018-2030 (USD Million)
Fig. 58 France
Fig. 59 France market estimates and forecast, 2018-2030 (USD Million)
Fig. 60 Italy
Fig. 61 Italy market estimates and forecast, 2018-2030 (USD Million)
Fig. 62 Asia Pacific
Fig. 63 Asia Pacific market estimates and forecast, 2018-2030 (USD Million)
Fig. 64 Japan
Fig. 65 Japan market estimates and forecast, 2018-2030 (USD Million)
Fig. 66 China
Fig. 67 China market estimates and forecast, 2018-2030 (USD Million)
Fig. 68 India
Fig. 69 India market estimates and forecast, 2018-2030 (USD Million)
Fig. 70 South Korea
Fig. 71 South Korea market estimates and forecast, 2018-2030 (USD Million)
Fig. 72 Australia
Fig. 73 Australia market estimates and forecast, 2018-2030 (USD Million)
Fig. 74 Latin America
Fig. 75 Latin America market estimates and forecast, 2018-2030 (USD Million)
Fig. 76 Brazil
Fig. 77 Brazil market estimates and forecast, 2018-2030 (USD Million)
Fig. 78 Mexico
Fig. 79 Mexico market estimates and forecast, 2018-2030 (USD Million)
Fig. 80 Argentina
Fig. 81 Argentina market estimates and forecast, 2018-2030 (USD Million)
Fig. 82 Middle East & Africa
Fig. 83 Middle East & Africa market estimates and forecast, 2018-2030 (USD Million)
Fig. 84 South Africa
Fig. 85 South Africa market estimates and forecast, 2018-2030 (USD Million)
Fig. 86 UAE
Fig. 87 UAE market estimates and forecast, 2018-2030 (USD Million)
Fig. 88 Saudi Arabia
Fig. 89 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Fig. 90 Participant categorization
Fig. 91 Strategy mapping
Fig. 92 Strategic framework
Fig. 93 Company market share analysis

Companies Mentioned

  • Pfizer Inc.
  • Sandoz International GmbH
  • GSK Group of Companies.
  • AbbVie Inc
  • Merck & Co., Inc
  • Xellia PHARMACEUTICALS
  • Theravance Biopharma
  • AuroMedics Pharma LLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJuly 2022
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 4.54 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.6 Billion
Compound Annual Growth Rate4.6%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Peptide Antibiotics Market by Type, Disease, Route of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Peptide Antibiotics Market by Type, Disease, Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Peptide Antibiotics Global Market Report 2024 - Product Image

Peptide Antibiotics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
2024 Global Forecast for Peptide Antibiotics Marke (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Peptide Antibiotics Marke (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Antibiotic Resistance Market Size, Share & Trends Analysis Report by Disease (cUTI, CDI), Pathogen, Drug Class, Mechanism of Action, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Antibiotic Resistance Market Size, Share & Trends Analysis Report by Disease (cUTI, CDI), Pathogen, Drug Class, Mechanism of Action, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Europe Antibiotics Market Size, Share & Trends Analysis Report by Drug Class (Cephalosporin, Penicillin), Type (Branded Antibodies, Generic Antibodies), Action Mechanism, Country, and Segment Forecasts, 2024-2030 - Product Image

Europe Antibiotics Market Size, Share & Trends Analysis Report by Drug Class (Cephalosporin, Penicillin), Type (Branded Antibodies, Generic Antibodies), Action Mechanism, Country, and Segment Forecasts, 2024-2030

  • Report
  • 80 Pages
  • Europe
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.